Swedish Communications Stock News

OM:INSTAL
OM:INSTALConstruction

Instalco (OM:INSTAL) Q4 Margin Uptick To 2.8% Tests Bullish Recovery Narrative

Instalco (OM:INSTAL) FY 2025 headline numbers set the tone Instalco (OM:INSTAL) has wrapped up FY 2025 with fourth quarter revenue of SEK3.8b and basic EPS of SEK0.49, putting concrete numbers around the company’s latest trading update. The company has seen quarterly revenue range from SEK3.0b to SEK3.8b through 2025, while basic EPS has moved between SEK0.19 and SEK0.49. This gives investors a clear view of how the top line and per share earnings have tracked through the year. With trailing...
OM:CRAD B
OM:CRAD BMedical Equipment

C Rad (OM:CRAD B) Margin Collapse To 2.4% Challenges High P E Narrative

How C-Rad (OM:CRAD B) Finished FY 2025 C-Rad (OM:CRAD B) closed out FY 2025 with fourth quarter revenue of 105.8 million SEK and EPS of 0.05 SEK, capping a year where trailing 12 month revenue came in at 441.9 million SEK and EPS at 0.31 SEK. Over recent periods the company has seen quarterly revenue move between 100.1 million SEK and 121.5 million SEK, while EPS has ranged from a loss of 0.24 SEK in early 2025 to 0.43 SEK in late 2024. This sets the scene for investors to weigh forecast...
OM:VERT B
OM:VERT BSoftware

Vertiseit (OM:VERT B) Margin Compression Challenges Bullish Growth Narratives After FY 2025 Results

Vertiseit (OM:VERT B) has wrapped up FY 2025 with fourth quarter revenue of SEK186.8 million, basic EPS of SEK0.22 and net income of SEK6.7 million, giving investors a fresh read on both growth and profitability. Over recent periods, the company has seen quarterly revenue move between SEK150.7 million and SEK202.8 million, while basic EPS has ranged from a loss of SEK0.56 to a profit of SEK0.48, setting a wide but clear context for how FY 2025 played out on the income line. With trailing 12...
OM:VESTUM
OM:VESTUMConstruction

Vestum FY 2025 Loss Deepens Bearish Narrative Despite Q4 Revenue Of SEK 975 Million

Vestum FY 2025 earnings snapshot Vestum (OM:VESTUM) has wrapped up FY 2025 with fourth quarter revenue of SEK 975 million and a loss of SEK 93 million, which translated to EPS of SEK 0.25. Over recent periods, the company has seen quarterly revenue range from SEK 359 million in Q4 2024 to SEK 1,019 million in Q3 2024, while EPS has moved between SEK 0.06 in Q3 2025 and SEK 0.45 on a trailing 12 month basis in Q3 2024. This leaves investors weighing revenue traction against consistently...
OM:MEKO
OM:MEKORetail Distributors

Meko (OM:MEKO) Earnings Strain And 0.2% Net Margin Reinforce Bearish Narratives

Meko (OM:MEKO) has wrapped up FY 2025 with Q4 revenue of SEK4.6b and a basic EPS loss of SEK0.20, alongside trailing twelve month revenue of SEK18.4b and EPS of SEK0.65 that highlight how thin earnings have become. Over recent periods the company has seen quarterly revenue move in a tight band between SEK4.5b and SEK4.8b, while basic EPS has swung from a Q1 profit of SEK0.86 to small losses in Q2 and Q4. This frames a year where the top line held steady but profitability stayed under...
OM:MYCR
OM:MYCRElectronic

How Mycronic’s 2026 Guidance, Dividend Hike And New Order At Mycronic (OM:MYCR) Has Changed Its Investment Story

In early February 2026, Mycronic reported its fourth-quarter and full-year 2025 results, with quarterly sales of SEK 2,021 million and annual net income of SEK 1.56 billion, while also issuing 2026 net sales guidance of SEK 8.25 billion and announcing a replacement Prexision 8 Evo order worth US$21–24 million from an Asian customer. The board’s decision to raise the annual dividend to SEK 3.25 per share alongside softer quarterly earnings and fresh mask-writer demand highlights how Mycronic...
OM:GENO
OM:GENOLife Sciences

Genovis (OM:GENO) Margin Compression To 17.7% Tests Bullish Growth Narratives

Genovis AB (publ.) (OM:GENO) has wrapped up FY 2025 with fourth quarter revenue of 40.999 million SEK and basic EPS of 0.10 SEK, while the trailing twelve months show revenue of 132.945 million SEK and EPS of 0.36 SEK. These figures help set the tone for how the market will read the results. The company has seen quarterly revenue move from 28.9 million SEK in Q4 2024 to 40.999 million SEK in Q4 2025, with EPS over the same quarters shifting from 0.07 SEK to 0.10 SEK. Investors will be...
OM:DVYSR
OM:DVYSRBiotechs

Devyser Diagnostics Q4 Profit Of 13.6m SEK Tests Longstanding Loss Narrative

Devyser Diagnostics (OM:DVYSR) has wrapped up FY 2025 with fourth quarter revenue of 72 million SEK and EPS of 0.82 SEK, putting a clean set of numbers in front of investors off a share price of 102.6 SEK. Over recent periods the company has seen revenue move from 48.7 million SEK in Q3 2024 to 64.2 million SEK in Q4 2024 and then to 72 million SEK in Q4 2025. Quarterly EPS has swung from a loss of 1.41 SEK in Q3 2024 and 0.19 SEK in Q4 2024 to a profit of 0.82 SEK in Q4 2025, setting up a...
OM:NYAB
OM:NYABConstruction

Nyab (OM:NYAB) Margin Compression Challenges Bullish Efficiency Narrative In FY 2025 Results

Nyab (OM:NYAB) has wrapped up FY 2025 with fourth quarter revenue of €154.6m, net income of €9.0m and basic EPS of €0.01, against a backdrop of 12 month revenue of €547.6m and EPS of €0.03. Over recent periods the company has seen quarterly revenue move from €93.8m in Q3 2024 to €150.3m in Q3 2025 and from €116.5m in Q4 2024 to €154.6m in Q4 2025. Basic EPS shifted from €0.0094 and €0.0130 in those prior quarters to €0.0119 and €0.01. Investors therefore have a clear run of top line and EPS...